Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma
Authors:
- 29 August 2013
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 108 (6) , 414-419
Abstract
Background The aim of this study was to investigate the clinical significances and prognostic value of CD133 and CD44 (markers of cancer stem-like cells, CSCs), and vasculogenic mimicry (VM) in renal cell carcinoma (RCC). Methods Immunohistochemistry was performed to detect CD133 and CD44 expression and VM in 110 RCC patients proven to exhibit de novo metastases after radical nephrectomy. Results In RCC, positive rates of 27.3%, 20.9%, and 21.8% were obtained for CD44, CD133, and VM, respectively. CD44 was significantly associated with tumor size, grade, stage, and histological type. CD44 expression may serve as a predictor of the number of metastases sites in RCC. CD133 expression correlated with tumor grade, stage, histological type, and tumor location. VM was positively associated with tumor grade and stage. Microvessel density (MVD) positively corresponded to tumor size, grade, and stage. CD133 expression was not associated with MVD, but significantly correlated with VM. CD44 expression correlated marginally with VM, but was found to have a significantly association with MVD. A close relationship between CSCs, MVD, and VM was established. The overall survival times of patients with CD133-high positive, CD44-high positive, VM-positive, and MVD J. Surg. Oncol. 2013; 108:414–419.Keywords
This publication has 38 references indexed in Scilit:
- IDENTIFICATION OF CD133+/NESTIN+ PUTATIVE CANCER STEM CELLS IN NON-SMALL CELL LUNG CANCERBiomedical Papers, 2010
- Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cellsJournal of Experimental & Clinical Cancer Research, 2010
- Predicting cancer-control outcomes in patients with renal cell carcinomaCurrent Opinion in Urology, 2009
- Metastatic renal cell cancer treatments: An indirect comparison meta-analysisBMC Cancer, 2009
- Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor CellsGastroenterology, 2007
- Multi-Institutional Validation of a New Renal Cancer–Specific Survival NomogramJournal of Clinical Oncology, 2007
- Isolation and Characterization of Multipotent Progenitor Cells from the Bowman’s Capsule of Adult Human KidneysJournal of the American Society of Nephrology, 2006
- Applying the principles of stem-cell biology to cancerNature Reviews Cancer, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Stem cells, cancer, and cancer stem cellsNature, 2001